Different inhibition pattern of the nucleic acid metabolism after in vitro treatment with titanocene and vanadocene dichlorides.
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D002286:Carcinoma, Ehrlich Tumor / Q000378:metabolism*; D004261:DNA Replication / Q000187:drug effects*; D007700:Kinetics; D051379:Mice; D009363:Neoplasm Proteins / Q000096:biosynthesis*; D009942:Organometallic Compounds / Q000494:pharmacology*; D012334:RNA, Neoplasm / Q000096:biosynthesis*; D014025:Titanium / Q000494:pharmacology*; D014639:Vanadium / Q000494:pharmacology*; D017968:Vanadium Compounds
D000970:Antineoplastic Agents; D009363:Neoplasm Proteins; D009942:Organometallic Compounds; D012334:RNA, Neoplasm; D017968:Vanadium Compounds; D014639:Vanadium; C030754:vanadocene dichloride; D014025:Titanium; C020528:titanocene dichloride